Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04BWH
|
||||
Former ID |
DNC013847
|
||||
Drug Name |
Benzo[b]thiophen-2-ylboronic acid
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C8H7BO2S
|
||||
Canonical SMILES |
B(C1=CC2=CC=CC=C2S1)(O)O
|
||||
InChI |
1S/C8H7BO2S/c10-9(11)8-5-6-3-1-2-4-7(6)12-8/h1-5,10-11H
|
||||
InChIKey |
YNCYPMUJDDXIRH-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [2] | |
Beta-lactamase | Target Info | Inhibitor | [1] | ||
BioCyc Pathway | Anandamide degradation | ||||
KEGG Pathway | Retrograde endocannabinoid signaling | ||||
PANTHER Pathway | Anandamide degradation | ||||
References | |||||
REF 1 | J Med Chem. 2007 Nov 15;50(23):5644-54. Epub 2007 Oct 23.Optimizing cell permeation of an antibiotic resistance inhibitor for improved efficacy. | ||||
REF 2 | J Med Chem. 2008 Nov 27;51(22):7057-60.Discovery of boronic acids as novel and potent inhibitors of fatty acid amide hydrolase. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.